• Greeting
• Corporate Philosophy
• Corporate Profile
• Board of Directors
• Organizational Chart
• History
• Locations
• Seikagaku; Quick Overview

Greeting

A Global R&D-Oriented Pharmaceutical Company Focusing on Glycoscience

Seikagaku is committed to improving the quality of life of people around the world by offering unique pharmaceutical products and medical devices, mainly hyaluronic acid formulations. As a manufacturer of reagents and diagnostics, we are also dedicated to the advancement of basic and applied research both in Japan and overseas.

The pharmaceutical business environment is currently undergoing major changes—healthcare cost containment measures are being implemented worldwide; major M&As are being made in Japan and overseas; revolutionary technological advances are emerging as a result of drug development research; and the level of competition in developing new drugs is growing more intense. Given these conditions, Seikagaku is focusing its research and development efforts on its strongest field of specialization, glycoscience, and has established a 10-Year Vision that reflects our goal of becoming an internationally competitive player as a Global Category Pharma.
As the first step toward this goal, we have established a three-year mid-term management plan (starting in FY 2009) that outlines our strategy as a global, powerful, sustainable company, and we are now cultivating our foundation and developing systems to help us achieve our goals.

Recent research has shown that glycoconjugates, an area in which Seikagaku has specialized for many years, are deeply involved in various life processes, and this knowledge has expanded the scope and potential applications of glycoscience in drug development. As a global R&D-oriented pharmaceutical company, Seikagaku will continue to offer highly innovative pharmaceuticals inspired by glycoscience and provide unique, high-quality products backed by reliable scientific information. We are keenly aware of the mission and social responsibilities with which Seikagaku has been entrusted as a result of our position as a pharmaceutical company. This is reflected in our policy to uphold a high level of management transparency backed by high ethical standards. We will remain steadfast to our guiding principles in cultivating and maintaining the trust of our stakeholders.

Ken Mizutani
President, CEO